Autism Spectrum Disorder Medication Treatment Study (RILISE)

The RILISE study is currently recruiting participants.

The Province of Ontario Neurodevelopmental Network (POND) is conducting new research to understand how genes affect the brain and behaviour in Autism Spectrum Disorder (ASD). We are looking for children ages 6 to 17 to take part in trials of new medications to treat the core symptoms of ASD.

Doctors at the Offord Centre for Child Studies (OCCS) at McMaster University/McMaster Children’s Hospital are studying a new medication (riluzole) for the treatment of children and adolescents with Autism Spectrum Disorder (ASD). Participation will require approximately 9 visits to OCSS at Chedoke Hospital over a 4 month period. Each visit will take about two hours. Questionnaires about symptoms and side effects will be completed at each visit, and blood samples will be required at 5 of the appointments in order to monitor side effects. Medication will be provided at no cost during the study, and expenses related to participation (such as parking) will be paid for by the investigators. Participants will also receive compensation for their time and effort. If you (or your child) meet the criteria below and are interested in participating in this study, please contact Dr. Teresa  Bennett’s Research Office at 905-521-2100 extension 74906 for further information.

Criteria for participation:

  • child between the ages of 6 and 17


  • has ASD

If you are interested in participating, contact: Iulia Patriciu,  905-521-2100 x 74906